SCHEMBL6501849

SCHEMBL6501849

CCN(CCC#N)C1(C2CCN(c3ccc4c(=O)c(C(=O)O)cn(C5CC5)c4c3OC)C2)CC1

nearest known ligand 0.63

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 7/20 0.63
CYP3A4 P08684 1/20 0.56
KDM4E B2RXH2 7/20 0.41
ALDH1A1 P00352 4/20 0.41
HPGD P15428 4/20 0.41
POLB P06746 2/20 0.41
TDP1 Q9NUW8 2/20 0.41
HSD17B10 Q99714 2/20 0.41
PRKD3 O94806 1/20 0.41
ALOX15 P16050 1/20 0.41
OPRM1 P35372 1/20 0.41
CLK2 P49760 1/20 0.41
CLK4 Q9HAZ1 1/20 0.41
GSK3B P49841 2/20 0.39
LMNA P02545 2/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MEN1 O00255 1/20 0.37
KMT2A Q03164 1/20 0.37
CYP2C19 P33261 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6528792 0.92 KCNH2 (0.61) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL6505978 0.85 KCNH2 (0.62) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL6527134 0.83 KCNH2 (0.66) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL6527249 0.83 KCNH2 (0.81) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL6527762 0.81 KCNH2 (0.71) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL5460667 0.80 KCNH2 (0.37) KCNH2CYP3A4
SCHEMBL6504808 0.79 KCNH2 (0.72) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL6528801 0.79 KCNH2 (0.72) KCNH2CYP3A4KDM4EALDH1A1HPGD
SCHEMBL5459342 0.79 KCNH2 (0.38) KCNH2CYP3A4
SCHEMBL6528390 0.79 KCNH2 (0.56) KCNH2CYP3A4KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2005049602-A1 QUINOLONE ANTIBACTERIAL AGENTS WARNER-LAMBERT COMPANY LLC (US) 2005-06-02 WO disclosed
WO-2005042491-A1 BENZAZEPINE DERIVATIVES AND METHODS OF PROPHYLAXIS OR TREATMENT OF 5HT2C RECEPTOR ASSOCIATED DISEASES ARENA PHARMACEUTICALS, INC. (US) 2005-05-12 WO disclosed